Detecting frontotemporal dementia syndromes using MRI biomarkers. 2019

Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark. Electronic address: marie.bruun@regionh.dk.

Diagnosing frontotemporal dementia may be challenging. New methods for analysis of regional brain atrophy patterns on magnetic resonance imaging (MRI) could add to the diagnostic assessment. Therefore, we aimed to develop automated imaging biomarkers for differentiating frontotemporal dementia subtypes from other diagnostic groups, and from one another. In this retrospective multicenter cohort study, we included 1213 patients (age 67 ± 9, 48% females) from two memory clinic cohorts: 116 frontotemporal dementia, 341 Alzheimer's disease, 66 Dementia with Lewy bodies, 40 vascular dementia, 104 other dementias, 229 mild cognitive impairment, and 317 subjective cognitive decline. Three MRI atrophy biomarkers were derived from the normalized volumes of automatically segmented cortical regions: 1) the anterior vs. posterior index, 2) the asymmetry index, and 3) the temporal pole left index. We used the following performance metrics: area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. To account for the low prevalence of frontotemporal dementia we pursued a high specificity of 95%. Cross-validation was used in assessing the performance. The generalizability was assessed in an independent cohort (n = 200). The anterior vs. posterior index performed with an AUC of 83% for differentiation of frontotemporal dementia from all other diagnostic groups (Sensitivity = 59%, Specificity = 95%, positive likelihood ratio = 11.8, negative likelihood ratio = 0.4). The asymmetry index showed highest performance for separation of primary progressive aphasia and behavioral variant frontotemporal dementia (AUC = 85%, Sensitivity = 79%, Specificity = 92%, positive likelihood ratio = 9.9, negative likelihood ratio = 0.2), whereas the temporal pole left index was specific for detection of semantic variant primary progressive aphasia (AUC = 85%, Sensitivity = 82%, Specificity = 80%, positive likelihood ratio = 4.1, negative likelihood ratio = 0.2). The validation cohort provided corresponding results for the anterior vs. posterior index and temporal pole left index. This study presents three quantitative MRI biomarkers, which could provide additional information to the diagnostic assessment and assist clinicians in diagnosing frontotemporal dementia.

UI MeSH Term Description Entries
D007090 Image Interpretation, Computer-Assisted Methods developed to aid in the interpretation of ultrasound, radiographic images, etc., for diagnosis of disease. Image Interpretation, Computer Assisted,Computer-Assisted Image Interpretation,Computer-Assisted Image Interpretations,Image Interpretations, Computer-Assisted,Interpretation, Computer-Assisted Image,Interpretations, Computer-Assisted Image
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
January 2014, Biomarkers in medicine,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
December 2005, Experimental neurology,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
January 2022, Frontiers in neuroscience,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
February 2013, European journal of nuclear medicine and molecular imaging,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
January 2018, Handbook of clinical neurology,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
April 2022, Human brain mapping,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
November 2017, Jacobs journal of medical diagnosis and medical imaging,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
October 2018, Annals of clinical and translational neurology,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
July 2017, Nature reviews. Neurology,
Marie Bruun, and Juha Koikkalainen, and Hanneke F M Rhodius-Meester, and Marta Baroni, and Le Gjerum, and Mark van Gils, and Hilkka Soininen, and Anne M Remes, and Päivi Hartikainen, and Gunhild Waldemar, and Patrizia Mecocci, and Frederik Barkhof, and Yolande Pijnenburg, and Wiesje M van der Flier, and Steen G Hasselbalch, and Jyrki Lötjönen, and Kristian S Frederiksen
December 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration,
Copied contents to your clipboard!